| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/12/2009 | US7531621 Of the formula, [Cha7,11, des-Met8, Nle18, Tyr34]hPTH(1-34)NH2; disorders of the central nervous system, metabolism, pancreas, and hypothalmus; irregular blood pressure, male infertility; agonists or antagonists |
| 05/12/2009 | US7531516 Antiinflammatory agents; multiple sclerosis; inflamamtory bowel disorders; antitumor agents; sepsis |
| 05/12/2009 | US7531515 Cancer treatment by administration of a synthetic peptide comprising a sequence of amino acids within the p53 protein and a membrane penetrating leader sequence |
| 05/12/2009 | US7531514 Orally administered peptides synergize statin activity |
| 05/12/2009 | US7531513 Therapeutic preparation of very high purity FVIIa and method for obtaining same |
| 05/12/2009 | US7531512 Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes |
| 05/12/2009 | US7531511 Injecting fibroblast growth factor-2 directly into the myocardium |
| 05/12/2009 | US7531509 Cationic peptide that inhibits the growth of both grampositive and/or gramnegative bacteria; isolated from the hemocytes of the sea squirt; can be used to treat antibiotic resistant tuberculosis, pneumonia, and urinary pathologies |
| 05/12/2009 | US7531508 The variant has an altered A-B loop and is therefore predicted to possess altered receptor binding properties; for use in therapy or diagnosis of a disease in which human growth hormone is implicated |
| 05/12/2009 | US7531504 Peptide antagonists of zonulin that bind to the zonula occludens receptor, yet do not physiologically modulate the opening of mammalian tight junctions; tablets, capsules |
| 05/12/2009 | US7531502 Diagnostic conjugate useful for intracellular imaging and for differentiating between tumor- and non-tumor cells |
| 05/12/2009 | US7531501 Method of treating endothelial injury |
| 05/12/2009 | US7531356 exposing host cells in vitro that comprising genetic vector consisting a polynucleotide and a heterologous reporter gene operably linked to the polynucleotide, to test agents, then measuring and comparing the reporter gene expression level to that of a control cell that is not exposed to the test agent |
| 05/12/2009 | US7531352 Inducible plasmid vector encoding TGF-β and use thereof |
| 05/12/2009 | US7531342 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences |
| 05/12/2009 | US7531332 esterifying L-PHE to generate a lower alkyl ester of L-phenylalanine, condensing the lower alkyl ester of L-phenylalanine with N-acyl-L-aspartic anhydride to obtain a lower alkyl ester of N-acyl- alpha -L-aspartyl-L-phenylalanine, separating, hydrogenating to form lower alkyl ester of alpha ASP-PHE |
| 05/12/2009 | US7531326 Chimeric retinoid X receptors and their use in a novel ecdysone receptor-based inducible gene expression system |
| 05/12/2009 | US7531325 Preparing genetically engineered polypeptides/zymogens for pharmaceutical or food composition |
| 05/12/2009 | US7531324 Interferon-alpha polypeptides and conjugates |
| 05/12/2009 | US7531321 Fibroblast growth factor-like molecules and uses thereof |
| 05/12/2009 | US7531320 Modulation of β-catenin/TCF-activated transcription |
| 05/12/2009 | US7531313 Screening for agents that modulate relaxin function |
| 05/12/2009 | US7531311 determining the amount of a polynucleotide sequence or a fragment of at least 20 consecutive nucleotides in a test sample and comparing the amount with that from a control, wherein an increase indicates a gastrointestinal disorder |
| 05/12/2009 | US7531310 Methods of diagnosing Crohn's disease by measuring expression level of RNA encoding human G-protein coupled receptor, HGPRBMY11 |
| 05/12/2009 | US7531304 Method for screening FGFR-4 agonists |
| 05/12/2009 | US7531300 contacting drugs with protein kinases, then detecting the binding activity, selecting the drugs that binds to the kinase, contacting the selected drugs with breast cancer cells and further selecting the drugs that suppresses cell growth of breast cancer cells; screening for antiproliferative agents |
| 05/12/2009 | US7531183 Biologically active hemagglutinin from type A Clostridium botulinum and methods of use |
| 05/12/2009 | US7531182 Vaccine against foot-and-mouth disease |
| 05/12/2009 | US7531181 Gp120 specific antigens and uses thereof |
| 05/12/2009 | US7531180 Chimeric alphavirus replicon particles |
| 05/12/2009 | US7531179 Bipolymer conjugate comprising botulin-a peptide for use in conferring tolerance to clostridial toxin |
| 05/12/2009 | US7531178 Immunoadhesin comprising a glycoprotein VI domain |
| 05/12/2009 | US7531177 Surface protein of leptospira |
| 05/12/2009 | US7531176 Brachyspira pilosicoli 72 kDa outer-membrane protein and diagnostic and therapeutic uses thereof |
| 05/12/2009 | US7531173 Ophthalmic composition comprising vascular endothelial growth factor antagonist for use in prevention and treatment of vision defects |
| 05/12/2009 | US7531172 administering vascular endothelial growth factor (VEGF) inhibitors, to reduce or prevent hypertension |
| 05/12/2009 | US7531171 Antibodies to non-functional P2X7 receptor |
| 05/12/2009 | CA2643508A1 Process for obtaining high efficiency human albumin for use in detoxification therapy |
| 05/12/2009 | CA2417316C Process for the preparation of amylase inhibitor |
| 05/12/2009 | CA2416869C Vaccines |
| 05/12/2009 | CA2415749C Method of producing infectious reovirus |
| 05/12/2009 | CA2400143C Recombinant conglutinin and producing method thereof |
| 05/12/2009 | CA2396052C Increased lysine production by gene amplification |
| 05/12/2009 | CA2284079C Immunotoxins and methods of inducing immune tolerance |
| 05/12/2009 | CA2272338C Immunization of infants |
| 05/12/2009 | CA2244195C Pin m iii gene in white pine |
| 05/12/2009 | CA2213254C Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism |
| 05/12/2009 | CA2201940C Method of treating diabetes mellitus using kgf |
| 05/12/2009 | CA2157864C Cloning and recombinant production of vespid venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 05/12/2009 | CA2141430C Nucleic acid sequence amplification |
| 05/12/2009 | CA2109977C Giardia vaccines |
| 05/09/2009 | CA2611540A1 Sugar chain-containing albumin, production method thereof and use thereof |
| 05/09/2009 | CA2610098A1 Production of recombinant human hemoglobin using pichia yeast |
| 05/07/2009 | WO2009059328A2 Multi- component l2 vaccine for prevention of human papillomavirus infection |
| 05/07/2009 | WO2009059325A2 Multitype hpv peptide compositions and methods for treatment or prevention of human papillomavirus infection |
| 05/07/2009 | WO2009059305A2 Red fluorescent proteins with enhanced bacterial expression, increased brightness and reduced aggregation |
| 05/07/2009 | WO2009059225A2 Analgesia with minimal tolerance and dependence by a mu opioid receptor agonist that also binds filamin a |
| 05/07/2009 | WO2009059192A1 Materials and methods for gene mediated therapy of psychiatric disorders |
| 05/07/2009 | WO2009059082A2 Method, composition, and article of manufacture for providing alpha-1 antitrypsin |
| 05/07/2009 | WO2009059078A2 Method of genetically altering and producing allergy free cats |
| 05/07/2009 | WO2009059011A2 Hla-dr binding peptides and their uses |
| 05/07/2009 | WO2009058947A2 Plants with altered root architecture, related constructs and methods involving genes encoding exostosin family polypeptides and homologs thereof |
| 05/07/2009 | WO2009058927A1 Zymomonas with improved ethanol production in medium containing concentrated sugars and acetate |
| 05/07/2009 | WO2009058766A2 Methods of regulating the expression of mir-34a and p18ink4c |
| 05/07/2009 | WO2009058734A1 Compounds exhibiting glucagon antagonist and glp-1 agonist activity |
| 05/07/2009 | WO2009058564A2 Immunosuppressive polypeptides and nucleic acids |
| 05/07/2009 | WO2009058446A1 Recombinant factor viii having increased stability |
| 05/07/2009 | WO2009058440A2 Lantibiotics from bifidobacterium longum and uses thereof |
| 05/07/2009 | WO2009058363A1 Antibody to rage and uses for in vivo imaging or for targeting therapy |
| 05/07/2009 | WO2009058285A2 PORCINE DC-SIGN, ICAM-3 AND LSECtin AND USES THEREOF |
| 05/07/2009 | WO2009058014A2 Polypeptides involved in neuronal regeneration-associated gene expression |
| 05/07/2009 | WO2009057461A1 Therapeutic agent for diabetes |
| 05/07/2009 | WO2009057287A1 Food material for inhibiting the formation of osteoclast |
| 05/07/2009 | WO2009057282A1 Food material for inhibiting bone resorption |
| 05/07/2009 | WO2009057281A1 Food material for promoting the differentiation of osteoblast and inhibiting the differentiation of osteoclast |
| 05/07/2009 | WO2009057061A1 Transgenic plants and modulators for improved stress tolerance |
| 05/07/2009 | WO2009056651A1 Angiotensin-carrier formulation |
| 05/07/2009 | WO2009056597A1 Insect inhibiting plant serpin mutants |
| 05/07/2009 | WO2009056584A1 Anticomplement polypeptides of ixodes ricinus |
| 05/07/2009 | WO2009056580A1 Rabbit monoclonal antibody (mab cv152) anti-indoleamine 2 3-dioxygenase (ido) |
| 05/07/2009 | WO2009056566A2 Plants having enhanced yield-related traits and a method for making the same |
| 05/07/2009 | WO2009056490A1 NEW ANTIBODIES SPECIFIC OF THE β-AMYLOID PEPTIDES AND THEIR USES AS DIAGNOSTIC AGENTS OR DRUGS |
| 05/07/2009 | WO2009056342A1 Binding epitopes for g250 antibody |
| 05/07/2009 | WO2009056330A1 Soluble truncated apom proteins and medical uses thereof |
| 05/07/2009 | WO2009056268A1 An antigen associated with rheumatoid arthritis |
| 05/07/2009 | WO2009056076A1 Engineered pertactin variants for vaccine use |
| 05/07/2009 | WO2009056075A1 Pharmaceutical composition containing protein nmb0873 |
| 05/07/2009 | WO2009055936A1 Humanized anti-venezuelan equine encephalitis virus recombinant antibodies |
| 05/07/2009 | WO2009055907A1 Apoptin induces inhibition of bcr-abl kinase in cml cells |
| 05/07/2009 | WO2009055854A1 Chimeric relaxin polypeptides comprising an a and b chain derived from different relaxin family peptides |
| 05/07/2009 | WO2009030866A3 Method for purifying the factor viii and the von willebrand factor |
| 05/07/2009 | WO2009026172A3 New approach for designing diabetes drugs |
| 05/07/2009 | WO2009019012A3 Immobilisation of chelating groups for immobilised metal ion chromatography (imac) |
| 05/07/2009 | WO2009014835A3 Modified toxins |
| 05/07/2009 | WO2009012176A3 Methods and compositions for treating brain diseases |
| 05/07/2009 | WO2009007298A3 Allergens from aspergillus versicolor, and method of detecting a mold allergy caused by interior rooms |
| 05/07/2009 | WO2009007244A3 Replication deficient influenza virus for the expression of heterologous sequences |
| 05/07/2009 | WO2009005917A3 Methods of treating measles infectious disease in mammals |
| 05/07/2009 | WO2008153429A3 A protease from staphylococcus aureus, particularly spia or spib, peptides it recognises and their use |
| 05/07/2009 | WO2008133873A3 Fgf-binding fusion proteins |